Edward S. Kim

Also affiliated with City of Hope, Hope Foundation

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Relationship between MLH1, PMS2, MSH2 and MSH6 gene‐specific alterations and tumor mutational burden in 1057 microsatellite instability‐high solid tumors”.

Relationship between MLH1, PMS2, MSH2 and MSH6 gene‐specific alterations and tumor mutational burden in 1057 microsatellite instability‐high solid tumors

International Journal of Cancer(2020)10.1002/ijc.33115

N/A

0.770DataRank · unranked

169 citations

J. Nicholas Bodor, Alberto Puccini, Joanne Xiu, Richard M. Goldberg, Axel Grothey +8 more

A phase 2 single-arm study of berzosertib in combination with irinotecan in patients with progressive TP53 mutant gastric and gastro-esophageal junction cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4044

N/A

0.304DataRank · unranked

4 citations

Heloisa P. Soares, Farshid Dayyani, Anwaar Saeed, Edward S. Kim, Ning Jin +7 more

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO–Friends of Cancer Research Prior Therapies Work Group

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3854

N/A

0DataRank · unranked

31 citations

Diana Merino Vega, Lola A. Fashoyin‐Aje, Suparna Wedam, Gwynn Ison, Sol Atienza +9 more